Results 241 to 250 of about 2,034,935 (392)
Real-world safety and efficacy of avatrombopag in adults with immune thrombocytopenia: A systematic review and meta-analysis. [PDF]
Marı́a Luisa Lozano, David Valcárcel
openalex +1 more source
From Genomic and Epigenomic Maps to Medicines in Adult T‐Cell Leukemia/Lymphoma
ABSTRACT Adult T‐cell leukemia/lymphoma (ATL) is an aggressive and refractory hematologic malignancy that is caused by human T‐cell leukemia virus type‐1 (HTLV‐1) retrovirus. ATL results from a combination of viral latency and the accumulation of abnormalities throughout the genome, epigenome, transcriptome, and signaling pathways.
Kako Suzuki, Makoto Yamagishi
wiley +1 more source
Evaluating rilzabrutinib in the treatment of immune thrombocytopenia. [PDF]
Kuter DJ, Ghanima W.
europepmc +1 more source
Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review
Saifur Rahman Chowdhury +45 more
openalex +1 more source
This study was the largest sample size of first‐line third‐generation TKIs combined chemotherapy among advanced EGFRm NSCLC patients in the real world. It was never reported that aumolertinib and furmonertinib showed comparable PFS benefits to osimertinib in combination with chemotherapy. The overall safety profile remained acceptable. ABSTRACT FLAURA2
YuQin Jiang +9 more
wiley +1 more source
Platelet Count of Zero: A Case of Vancomycin-Induced Immune Thrombocytopenia. [PDF]
Gakhar SB +4 more
europepmc +1 more source
Mullins' syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra [PDF]
A.L. Manson +12 more
core +1 more source
Plasma levels and expression of interleukin‑37 in patients with immune thrombocytopenia
Feng Zhang +5 more
openalex +2 more sources

